Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_6035_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •About the Editor
- •Contents
- •Contributors
- •Abbreviations
- •Preface
- •1. Natural Products as Drug Candidates
- •1.1 Introduction
- •1.2 An array of natural products
- •1.2.1 Plant-derived natural products
- •1.2.2 Microbial natural products
- •1.3 Importance of analytical techniques
- •1.3.1 A glance at extraction techniques
- •1.3.2 Microbial culturing techniques
- •1.3.3 Outlook and perspectives in nanoparticles
- •1.4 Natural products as a guide in drug design and synthesis
- •1.5 Natural products as promising drug candidates
- •1.5.1 Antiviral drug candidates
- •1.5.2 Antiparasitic drug candidates
- •1.5.3 Neuroprotective agents
- •1.6 Conclusion
- •Keywords
- •References
- •2. Traditional Knowledge for Drug Discovery
- •2.1 Introduction
- •2.2 Databases on indian remedial flora, indigenous medicines, and phytochemicals
- •2.2.1 Cultural preservation
- •2.2.2 Sustainable practices
- •2.2.3 Biodiversity conservation
- •2.2.4 Health and medicine
- •2.2.5 Climate change adaptation
- •2.2.6 Interconnectedness and wisdom
- •2.3 History of traditional knowledge
- •2.3.1 Indigenous healing practices
- •2.3.2 Aboriginal dreamtime
- •2.3.3 Traditional agriculture
- •2.3.4 Traditional crafts
- •2.3.5 Indigenous cosmologies
- •2.3.6 Traditional music and dance
- •2.3.7 Traditional navigation
- •2.4 Traditional medicine in plant formulations
- •2.4.1 Ayurveda
- •2.4.2 Traditional chinese medicine
- •2.4.3 Indigenous healing practices
- •2.5 Drug discovery
- •2.6 Aspects of developing plant-based drugs
- •2.6.1 Selection criteria for plants
- •2.6.2 Plant material authentication
- •2.6.3 Extraction methods
- •2.6.4 Isolation and structure elucidation of bioactive components
- •2.6.5 Standardization of plant formulations
- •2.7 Conclusions
- •References
- •3. Herbal Healing: Plant-Based Natural Products
- •3.1 Introduction
- •3.2 Classification of secondary metabolites
- •3.2.1 Phenolic compounds
- •3.2.2 Terpenes
- •3.2.3 Alkaloids
- •3.3 History of natural products
- •3.4 Drug discovery from natural products
- •3.5 Drugs derived from the plants
- •3.6 Conclusions
- •Keywords
- •References
- •4. Natural Products with Antimicrobial Properties
- •4.1 Introduction
- •4.2 Plants as antimicrobial agents
- •4.3 Marine sources as antimicrobial agents
- •4.4 Antimicrobial products derived from microorganisms
- •4.5 Conclusions and future trends
- •Keywords
- •References
- •5. Natural Products with Immunomodulatory Properties
- •5.1 Introduction
- •5.2.1 Aloe vera (l.) burm.f. (family: asphodelaceae)
- •5.2.2 Andrographis paniculata (burm. f.) wall.ex.nees. (family: acanthaceae)
- •5.2.3 Acorus calamus l. (family: araceae)
- •5.2.4 Allium sativum l. (family: alliaceae)
- •5.2.5 Azadirachta indica a. juss. (family: meliaceae)
- •5.2.6 Argyreia speciosa (l.f.) sweet (family: convolvulaceae)
- •5.2.7 Bidens pilosa l. (family: asteraceae)
- •5.2.8 Baliospermum montanum (willd.) müll.arg. (family: euphorbiaceae)
- •5.2.9 Boerhaavia diffusa l. (family: nyctaginaceae)
- •5.2.10 Boswellia serrata roxb. excolebr. (family: burseraceae)
- •5.2.11 Camellia sinensis (l.) kuntze (family: theaaceae)
- •5.2.12 Capparis zeylanica l. (family: capparidaceae)
- •5.2.13 Calendula officinalis l. (family: asteraceae)
- •5.2.14 Chelidonium majus l. (family: papaveraceae)
- •5.2.15 Carica papaya l. (family: caricaceae)
- •5.2.26 Glycyrrhiza glabra l. (family: leguminosae)
- •5.2.27 Hypericum perforatum l. (family: hypericaceae)
- •5.2.28 Hippophae rhamnoides l. (family: elaeagnaceae)
- •5.2.29 Hydrastis canadensis l. (family: ranunculaceae)
- •5.2.30 Jatropha curcas l. (family: euphorbiaceae)
- •5.2.31 Mangifera indica l. (family: anacardiaceae)
- •5.2.32 Mollugo verticillata l. (family: molluginaceae)
- •5.2.33 Matricaria chamomilla l. (family: asteraceae)
- •5.2.34 Momordica charantia l. (family: cucurbitaceae)
- •5.2.35 Morinda citrifolia l. (family: rubiaceae)
- •5.2.36 Nigella sativa l. (family: ranunculaceae)
- •5.2.37 Nelumbo nucifera gaertn. (family: nymphaeceae)
- •5.2.38 Nerium oleander l. (family: apocynaceae)
- •5.2.39 Ocimum tenuiflorum l. (family: labiatae)
- •5.2.40 Premna tomentosa willd. (family: verbanaceae)
- •5.2.41 Plantago sp. (plantago major l. and plantago asiatica l.) (family: plantaginaceae)
- •5.2.42 Psoralea corylifolia l. (family: fabaceae)
- •5.2.43 Prunella vulgaris l. (family: lamiaceae)
- •5.2.44 Punica granatum l. (family: punicaceae)
- •5.2.45 Rhinacanthus nasutus (l.) kurz (family: acanthaceae)
- •5.2.46 Salvia officinalis l. (family: lamiaceae)
- •5.2.47 Tamarindus indica l. (family: leguminosae)
- •5.2.48 Tinospora cordifolia (willd.) miers (family: menispermaceae)
- •5.2.16 Centella asiatica (l.) urb. (family: umbelliferae)
- •5.2.17 Cichorium intybus l. (family: asteraceae)
- •5.2.18 Cryptolepis dubia (burm.f.) m.r. almeida (family: apocynaceae)
- •5.2.19 Citrus aurantiifolia (christm.) swingle (family: rutaceae)
- •5.2.20 Curcuma longa l. (family: zingiberaceae)
- •5.2.21 Desmodium gangeticum (l.) dc. (family: fabaceae)
- •5.2.22 Eclipta prostrata (l.) (family: asteraceae)
- •5.2.23 Phyllanthus emblica l. (family: euphorbiaceae)
- •5.2.24 Evolvulus alsinoides (l.) (family: convolvulaceae)
- •5.2.25 Ficus benghalensis l. (family: moraceae)
- •5.2.49 Terminalia chebula retz. (family: combretaceae)
- •5.2.51 Urtica dioica l. (family: urticaceae)
- •5.2.52 Withania somnifera (l.) dunal (cultivated var.) (family: solanaceae)
- •5.3 Traditional importance of research to society and researchers
- •5.4 Conclusion
- •Keywords
- •References
- •6. Natural Products with Anticancerous Properties
- •6.1 Introduction
- •6.2 Plant-derived anticancer compounds
- •6.2.1 Polyphenols
- •6.2.2 Flavanoids
- •6.2.3 Brassinosteroids
- •6.2.4 Vinca alkaloids
- •6.2.5 Taxanes
- •6.2.6 Campothecin derivatives
- •6.3 Microorganisms-based anticancer compounds
- •6.3.1 Primary metabolites
- •6.3.2 Secondary metabolites
- •6.4 Selected medicinal plants with anticancerous activities
- •6.4.1 Curcuma longa l.
- •6.4.2 Viscum album l.
- •6.4.3 Colchicum autumnale l.
- •6.4.4 Raphanus sativus l.
- •6.4.5 Tinospora cordifolia wild
- •6.4.6 Nigella sativa l.
- •6.5 Therapeutic enzymes
- •6.6 Future perspective
- •6.7 Conclusion
- •Keywords
- •References
- •7. Natural Products with Antiviral Properties
- •7.1 Introduction
- •7.2 Source of natural products with antiviral activity
- •7.3 Main components of natural products
- •7.3.1 Flavonoids
- •7.3.2 Polyphenols
- •7.3.3 Polysaccharides
- •7.3.4 Terpenoids
- •7.4 Mechanisms of action of natural compounds in viral infections
- •7.4.1 Direct antiviral effect
- •7.4.2 Anti-inflammatory effect in viral infections
- •7.4.3 Effect on autophagy process
- •7.6 Conclusions
- •Keywords
- •References
- •8. Approaches to Develop Drugs from Natural Products
- •8.1 Introduction
- •8.2 Scenario of drug discovery
- •8.3 Efficient drug discovery engines
- •8.4 Drug discovery approaches using plants
- •8.4.1 Plant selection for screening purpose
- •8.4.2 Authentication of plants
- •8.4.3 Types of molecular markers
- •8.5.1 Parallel approach
- •8.5.2 Sequential approach
- •8.6 Structure elucidation of isolated compounds
- •8.7 Biological screening of extracts/fraction/isolates
- •8.7.1 Cell culture-based assay
- •8.7.2 Dialysis
- •8.7.3 Microdialysis
- •8.7.4 Ultrafiltration
- •8.7.5 Chromatography
- •8.7.6 Ligand fishing
- •8.8 Limitations
- •8.9 Molecular modelling and np database
- •8.10 Future thrust
- •8.11 Conclusion
- •Keywords
- •References
- •9. Strategies for Isolation and Identification of Bioactive Molecules from Natural Sources
- •9.1 Introduction
- •9.2 Bioactive compounds in natural sources and their pharmacological properties
- •9.3.1 Selection of materials
- •9.3.3 Types and properties of solvent for extraction
- •9.4 Extraction methods (conventional and modern)
- •9.4.1 Conventional methods
- •9.4.2 Novel extraction methods
- •9.5 Concentration and purification of bioactive molecules using chromatographic techniques
- •9.5.1 Separation based on adsorption properties
- •9.5.2 Separation based on partition coefficient
- •9.5.3 Separation based on the molecular size
- •9.5.4 Separation based on ionic strength
- •9.5.5 Other modern separation techniques
- •9.6 Identification and characterization of bioactive molecules
- •9.6.1 Qualitative and quantitative techniques/chromatographic or nonchromatographic techniques
- •9.7 Conclusions
- •Keywords
- •References
- •10. Role of Omics in Natural Product-Based Drug Discovery
- •10.1 Introduction
- •10.2 Genomics and transcriptomics in natural product discovery
- •10.2.1 Case studies and examples of natural product discovery using genomics and transcriptomics
- •10.2.2 Limitations and challenges of using genomics and transcriptomics in natural product discovery
- •10.3 Proteomics and metabolomics in natural product discovery
- •10.3.1 Case studies and examples of natural product discovery using proteomics and metabolomics
- •10.4 Bioinformatics in natural product-based drug discovery
- •10.4.1 Role of bioinformatics in natural product-based drug discovery
- •10.4.2 The use of bioinformatics to predict and annotate natural product biosynthetic pathways, gene clusters, and metabolomics
- •10.7 Future perspectives and potential impact of omics in natural product-based drug discovery
- •10.9 Potential impact on drug discovery and development
- •10.10 Conclusion
- •Keywords
- •References
- •11. Natural Products from Endophytic Microorganisms
- •11.1 Introduction
- •11.1.1 Rational/why endophytes?
- •11.2 Diversity of endophytic microorganisms
- •11.2.1 Endophytic bacteria and endophytic actinomycetes
- •11.2.2 Endophytic fungi
- •11.3.1 ISolation methods
- •11.3.1.1.1 Dilution Plating
- •11.3.1.1.2 Direct Plating
- •11.3.2 Identification methods
- •11.4 Bioactive compounds from endophytic microorganisms
- •11.4.1 Antibiotics
- •11.4.2 Antifungal agents
- •11.4.3 Antimalarial agents
- •11.4.4 Antiviral agents
- •11.4.5 Anticancer agents
- •11.4.6 Antioxidants
- •11.5 Stepwise methods for natural product discovery from endophytic microorganisms
- •11.5.1 Plant selection rationale
- •11.5.2 Isolation and cultivation of endophytes
- •11.5.3 Characterization of endophytes
- •11.5.4 Extraction of natural products
- •11.5.5 Purification of natural products
- •11.6 Biosynthesis and strategies for the optimization of natural product discovery from endophytic microorganisms
- •11.6.1 Exploration of novel microbial sources
- •11.6.2 Metabolomics-guided discovery
- •11.6.3 Coculture
- •11.6.4 Genome mining
- •11.6.5 Modulation by ultraviolent irradiation
- •11.7 Future directions and challenges
- •11.7.1 Improving the efficiency and accuracy of screening methods
- •11.7.2 Enhancing the scalability and affordability of production methods
- •11.7.3 Ensure natural product safety and efficacy
- •11.8 Conclusions
- •References
- •12. Natural Products with Antidiabetic Properties
- •12.1 Introduction
- •12.2 Natural products that regulate glucose absorption
- •12.2.1 Serotonin-derived products
- •12.2.2 Butyl-isobutyl-phthalate from laminaria japonica
- •12.2.3 Bioactive compounds of allium cepa and allium sativum
- •12.2.4 Elatosides E and F of aralia elata
- •12.2.5 Bioactive compounds of bauhinia candicans and bauhinia forficate
- •12.3 Natural products that enhance insulin sensitivity
- •12.3.1 Astragalus membranaceus polysaccharides
- •12.3.2 Bioactive compounds of litchi chinensis
- •12.3.3 Bioactive compounds of fenugreek
- •12.3.4 Bioactive compounds of cinnamon
- •12.3.5 Bioactive compounds of gastrodia elata
- •12.3.6 Polysaccharides of dioscorea
- •12.3.7 Anthocyanins of blueberries
- •12.3.8 Bioactive compounds of psidium guajava
- •12.4.1 Gingerol from zingiber officinale
- •12.4.2 Curcumin from curcuma longa
- •12.4.3 Berberine
- •12.4.4 Capsaicin of pepper
- •12.4.5 Bioactive compounds of bitter melon
- •12.4.6 Ginsenosides of ginseng
- •12.4.7 Bioactive compounds of aloe vera
- •12.4.8 Quinides of coffee
- •12.4.9 Bioactive compounds of tinospora cordifolia
- •12.4.10 Bioactive compounds of pterocarpus marsupium
- •12.4.11 Eugenol of ocimum sanctum
- •12.4.12 Bioactive compounds of syzygium densiflorum
- •12.5 Clinical trials based on antidiabetic effects of natural products derived from plants
- •12.5.1 Gymnema sylvestre (gurmar)
- •12.5.2 Fenugreek (trigonella foenum-graecum)
- •12.5.3 Tea catechins
- •12.5.4 Coffee
- •12.5.5 Rosemary (rosmarinus officinalis)
- •12.6 Conclusion
- •12.7 Future scope
- •Keywords
- •References
- •13. Marine-Derived Natural Products with Anticancer Properties
- •13.1 Introduction
- •13.2 Marine bioactive compounds
- •13.3 Anticancer activity of marine plants
- •13.4 Anticancer agents from marine floras
- •13.5.1 Antioxidants
- •13.5.2 Immunomodulation and apoptosis
- •13.5.3 Nutritional values and anticancer effects
- •13.6 Nature and cancer chemotherapy
- •13.7 Marine organisms and cancer chemotherapy
- •13.8 Anticancer agents from marine floras
- •13.9 Marine plants
- •13.9.1 Macro algae (seaweed)
- •13.9.2 Mangroves and other higher plants
- •13.9.3 Cyanobacteria
- •13.9.4 Bacteria
- •13.9.5 Proteobacteria
- •13.9.6 Cyanobacteria
- •13.9.7 Actinomycetes
- •13.9.8 Marine fungi
- •13.9.9 Soft corals
- •13.9.10 Marine sponges
- •13.10 Anticancer bioactive antibiotics derived from marine sources
- •13.10.1 Polyphenols
- •13.10.2 Polysaccharides
- •13.10.3 Alkaloids
- •13.11 Other marine sources for anticancer compounds
- •13.11.1 Peptides
- •13.11.2 Plitidepsin
- •13.11.3 Trabectedin
- •13.11.4 Lurbinectedin
- •13.12 Marine natural products as anticancer drugs
- •13.13.1 Aquaculture/cultivation
- •13.13.2 Genetic engineering
- •13.13.3 Synthesis/semisynthesis/modification
- •13.14 Conclusions and future prospects
- •References
- •14. Natural Products as Novel Opportunities for Cathepsin Inhibitors
- •14.1 Introduction
- •14.2 Cysteine proteases (CPs)
- •14.2.1 Cathepsin
- •14.2.2 Structure and mechanism of action of cathepsins
- •14.3 NPs as cathepsins inhibitors
- •14.3.1 NPs From bacteria as cathepsin inhibitors
- •14.3.2 NPs from fungus as cathepsin inhibitors
- •14.3.3 NPs from marine organism as cathepsin inhibitors
- •14.3.4 NPs from plants as cathepsin inhibitors
- •14.4 Conclusion and future pespectives
- •Keywords
- •References
- •15. Phytoestrogens in Drug Discovery: A Focus on Mechanisms of Action and Safety Assessment
- •15.1 Introduction
- •15.2 Phytoestrogens and estrogen receptors
- •15.3 Nonestrogen receptor-mediated effects of phytoestrogens
- •15.3.1 Mitogen-activated protein kinase (MAPK) pathway
- •15.3.2 PI3K/AKT pathway
- •15.3.3 WNT pathway
- •15.3.4 G-protein-coupled estrogen receptor (GPER)
- •15.4 Structure–activity relationship (SAR) of phytoestrogens
- •15.4.1 Isoflavones
- •15.4.2 Lignans
- •15.4.3 Coumestans
- •15.4.4 Stilbenes
- •15.4.5 Diarylheptanoids
- •15.5 Comparing potency and efficacy of phytoestrogens on various pathways
- •15.5.1 Potency and efficacy of phytoestrogens on different pathways
- •15.5.2 Possible synergistic effects of phytoestrogens with other drugs
- •15.6 Effects of phytoestrogens on the human organs
- •15.7 Safety Assessment of phytoestrogens
- •15.7.1 Toxicity assays used to evaluate the safety of phytoestrogens
- •15.7.2 Potential adverse effects of phytoestrogens
- •15.8 Case study
- •15.8.1 Vaginal cellular differentiation assay
- •15.8.2 Changes in rat body weight
- •15.8.3 Changes in rats’ uterus weight
- •15.9 Current trends in phytoestrogen research
- •15.9.1 Publication trends
- •15.9.2 Analysis of contributing countries and contributing institutions
- •15.9.3 Analysis of contributing publishers and journals
- •15.9.4 Publication evolution and research areas
- •15.9.5 Limitations
- •15.10 Future directions
- •15.10.1 Exploration of unexplored plant sources
- •15.10.2 Understanding mechanisms of action
- •15.10.3 Synthesis of novel compounds
- •15.10.4 Development of SPERMs
- •15.10.5 Safety assessment
- •15.11 Conclusion
- •Keywords
- •References
- •16. Honey Bee Products with Antimicrobial Properties
- •16.1 Introduction
- •16.2 Honey
- •16.3 Bee bread (perga)
- •16.4 Bee pollen
- •16.5 Bee propolis
- •16.6 Conclusion
- •Keywords
- •References
- •17. Natural Products for the Prevention of Leaky Gut
- •17.1 Introduction
- •17.2 The physical and chemical barriers of the intestine
- •17.2.1 Thick mucus layer
- •17.2.2 Intestinal epithelial cells (IECS)
- •17.2.3 Intestinal junctional complexes
- •17.2.4 Lamina propria
- •17.2.5 Intestinal regulatory T cells
- •17.2.6 Intestinal alkaline phosphatase
- •17.2.7 Antimicrobial peptides
- •17.2.8 Lysozyme
- •17.3 Mechanistic view of factors leading to a leaky gut
- •17.3.1 Gut dysbiosis
- •17.3.2 Mucosal inflammation and oxidative stress
- •17.3.3 TJ disruption
- •17.3.4 Genetics
- •17.3.5 Drugs
- •17.4 Pathological implications of a leaky gut
- •17.5 Natural product improving gut microbial dysbiosis
- •17.5.1 Traditional herbs and polyherbal formulations managing gut micro flora
- •17.5.2 Phytocompounds in the management of intestinal barrier integrity through balancing gut microflora
- •17.6.1 Anti-inflammatory traditional medicine and plant extracts ameliorating intestinal mucosal injury
- •17.6.2 Plant active constituents preventing mucosal injury and oxidative damage
- •17.7 Traditional medicine and natural products upregulating the TJ proteins
- •17.7.1 Traditional medicine and herbal extracts promoting junction protein protection
- •17.7.2 Phytocompounds for junction protein protection
- •17.8 Natural products averting pathological conditions through maintaining intestinal barrier function
- •17.9 Conclusion
- •Keywords
- •References
- •18. Role of Natural Products in the Pharmacotherapy of Osteoporosis
- •18.1 Introduction
- •18.1.1 Effect of traditional chinese medicine (TCM)
- •18.1.2 Effect of malay traditional medicine
- •18.1.3 Antiosteoporotic agents extracted from plant sources
- •18.1.4 Treatment by different pigments
- •18.1.5 Other herbal sources
- •18.1.6 Natural plant-based alkaloids
- •18.1.7 Essential markers involved in bone formation and resorption for osteoporosis treatment
- •18.2 Conclusion
- •Keywords
- •References
- •19. Gel-Based Natural Therapeutics: Potential Alternatives to Traditional Drug Delivery Systems in Aquaculture
- •19.1 INtroduction
- •19.2 DDS
- •19.2.1 Water medication
- •19.3 Oral administration
- •19.3.1 Gavage

363
by phytoestrogens may contribute to their health benets, such as reducing cancer risk
and improving bone health. However, further research is needed to fully understand the
mechanisms and effects of phytoestrogens on the WNT pathway.
15.3.4 G-PROTEIN-COUPLED ESTROGEN RECEPTOR (GPER)
G-protein-coupled estrogen receptor (GPER), also known as G protein-coupled receptor
30 (GPCR), is a membrane-bound protein involved in various physiological processes (Liu
et al., 2019). Similar to other GPCRs, GPER consists of seven transmembrane domains
spanning the cell membrane. GPER also possesses an extracellular domain that enables it
to interact with ligands such as estrogens and phytoestrogens (Babiloni-Chust et al., 2022).
The mechanisms of GPER action entail complex molecular interactions and intracellular
signaling pathways. When estrogen binds to GPER, it activates several intracellular signaling
pathways, including calcium signaling and cyclic adenosine monophosphate production.
These pathways can trigger diverse biological responses, such as changes in gene expression,
cell growth, and differentiation. Recent studies indicate that GPER may also interact with
other signaling pathways, such as those related to insulin signaling and inflammation,
contributing to the range of physiological processes regulated by GPER (Huang et al., 2023).
Breast cancer is one of the leading causes of female cancer deaths globally, ranking
fth according to the International Agency for Research on Cancer (Xia et al., 2022). The
interaction between estrogens and ERs plays a critical role in the onset and progression of
breast cancer. Adjuvant endocrine therapy has proven effective in breast cancer prevention
by disrupting ligand-ER interactions in the estrogen-ER signaling pathway and reducing
endogenous estrogen levels. Recent research suggests that phytoestrogens can activate
GPER/GPR30, a membrane ER (Huang et al., 2023). Therefore, exploring the mechanisms
of GPER signaling pathways could lead to the development of novel phytoestrogen-based
dietary supplements for breast cancer prevention.
15.4 STRUCTURE–ACTIVITY RELATIONSHIP (SAR) OF PHYTOESTROGENS
Phytoestrogens can interact with ERs in the body , either mimicking or blocking the effects
of endogenous estrogens. Several studies have investigated the estrogenic properties of
phytoestrogens, revealing their weak estrogenic effects. Research utilizing the rat uterus
model to assess estrogenicity has demonstrated that phytoestrogens exhibit varying
affinities for ERs. However, in general, phytoestrogens display affinities at least a
thousand-fold lower than those of 17β-estradiol, as indicated by a binding constant (k
range of 1 × 10−9–1 × 10
−10
(Kuiper et al., 1998). The structure–activity relationship (SAR)
)
d
of phytoestrogens refers to the connection between the structure of these compounds and
their activity as estrogenic or antiestrogenic agents (Basu and Maier, 2018). SAR studies
can identify key structural features that contribute to their weak activity and guide the
development of more potent and selective molecules. The SAR of phytoestrogens has
been extensively studied, and phytoestrogens can be broadly categorized into four main
structural classes: isoflavones, lignans, coumestans, stilbenes, and diarylheptanoids.

364
15.4.1 ISOFLAVONES
Isoflavones are a type of organic compound belonging to the flavonoid family. They
share structural similarities with flavones and flavanones but have a distinctive 3-phenylchromen-4-one backbone structure, known as an isoflavone skeleton (Sohn et al., 2021). In
Figure 15.3, the letters A, B, and C represent the dif ferent rings of the isoflavone backbone.
The A ring consists of two fused benzene rings, while the C ring contains a single benzene
ring. The B ring is a heterocyclic ring, meaning it contains an atom other than carbon as
part of the ring structure—in this case, an oxygen atom.
FIGURE 15.3 Diagram illustrating the composition of isoflavones and their important members, consisting
of a six-membered ring (A ring) and a five-membered ring (C ring) interconnected by a heterocyclic oxygencontaining ring (B ring). (ChemDraw 20.1.1).
⏎
Isoavones are found in signicant amounts in soybeans, chickpeas, and other
legumes. Red clover, in particular, contains a higher concentration of isoavones than
soybeans, ranging from 0.5% to 2.5% by dry weight, which is 2–10 times greater (Sohn
et al., 2021). Phytoestrogens in natural foods are typically present as glycones, which are
molecules bound to monosaccharides, disaccharides, or polysaccharides through glycoside
linkages. This linkage occurs when an alcohol group reacts with an aldehyde group. Upon
ingestion, gut bacteria can hydrolyze glycones. In the case of soybeans, isoavones exist
as glycoconjugates, with approximately 80% being glucosides or analogs such as acetyl
and malonyl conjugates. Hydrolysis of glycones results in the separation of a sugar moiety
and an aglycone, which is the phytoestrogen component without the carbohydrate portion
(Sohn et al., 2021).
In an unpublished study conducted by the author, it was found that solid-state fermentation (SSF) occurs when there is little to no free water present and the substance is in a
solid-state matrix, typically a natural or synthetic support. The food and pharmaceutical
industries widely use SSF for the production of enzymes, organic acids, antibiotics,
and other products. SSF is also employed as a bioprocess to convert soybean isoavone
glycosides to aglycones, thereby enhancing the hydrolysis of glycoside linkages present
in isoavone glycosides that inhibit the absorption and biological activity of isoavones.
During SSF, microorganisms such as fungi or bacteria are inoculated onto a solid-state
matrix containing soybean meal, soy our, or soy protein isolate and allowed to grow and

365
generate enzymes, such as β-glucosidase. These enzymes cleave the sugar moieties from
the isoavone glycosides, leading to the formation of isoavone aglycones. The aglycones
produced during SSF exhibit higher biological activity than their glycoside counterparts,
making them more desirable for food and pharmaceutical applications. Moreover, SSF is
considered an eco-friendly and cost-effective method for converting soybean isoavone
glycosides to aglycones compared with other conventional methods involving the use of
strong acid solutions or higher temperatures.
Figure 15.3 illustrates some important isoavone forms of phytoestrogens. The
most common isoavones present in plants are genistein and daidzein, which possess
a hydroxyl (OH) group attached to the B ring. They closely resemble the structure of
endogenous estradiol, with two aromatic rings connected by a carbon‒carbon double bond.
Other prevalent isoavones include glycitein, biochanin A, formononetin, and prunetin
(Ramachandran et al., 2022). Studies have demonstrated that different substitutions and
modications to the basic isoavone structure can signicantly impact their binding
afnity to ERs, as well as their potency and selectivity as estrogen agonists or antagonists.
For instance, the substitution of hydroxyl groups at different positions on the isoavone
ring can inuence its binding afnity and potency. In particular, the presence of a hydroxyl
group at the 4’ position on the B-ring of the isoavone appears crucial for its estrogenic
activity. Additionally, the presence of a hydroxyl group at the 7 position on the A-ring
has been shown to enhance the estrogenic activity of isoavones (Cho et al., 2021).
Furthermore, the nature of the substituents in the isoavone can also impact its activity.
For example, the presence of a methoxy (–OCH3) group at position 4 on the B-ring of
isoavone has been found to increase its potency as an estrogen agonist. Conversely, the
presence of a hydroxyl group at the 5 position on the A-ring has been shown to decrease
the estrogenic activity of isoavones (Cho et al., 2021).
15.4.2 LIGNANS
Lignans represent another category of phytoestrogens that are found in flaxseeds, sesame
seeds, and whole grains (Swathi Krishna et al., 2022). They possess a complex structure
comprising two benzene rings connected by a butyrolactone unit, along with two side
chains attached to the rings (Tanwar et al., 2021). The side chains can vary depending on
the specific lignan, but they typically contain multiple methoxy groups (–OCH3) and/or
hydroxyl groups (–OH) (Figure 15.4) (Baldi et al., 2023). The estrogenic activity of lignans
is generally influenced by several structural features, including the number and position of
hydroxyl (–OH) groups on the molecules, the presence of an aromatic ring system, and the
stereochemistry of the molecule. The presence of hydroxyl groups is an important factor
that affects the estrogenic activity of lignans. Lignans with more hydroxyl groups generally
exhibit greater estrogenic activity, likely due to their capability to form hydrogen bonds
with ERs in the body (López-Rojas et al., 2022).
Enterolactone and enterodiol are two lignans that exhibit potent estrogenic activity
attributed to their multiple hydroxyl groups (Baldi et al., 2023). The position of hydroxyl
groups on the lignan molecule also plays a role in determining its estrogenic activity.

366
Lignans with hydroxyl groups in specic positions, such as the 7-hydroxyl group in
secoisolariciresinol from axseeds, have demonstrated higher estrogenic activity than those
lacking such groups. Alongside hydroxyl groups, the presence of an aromatic ring system
within the lignan molecule is crucial for its estrogenic activity. The aromatic ring system
can interact with ERs, inuencing their activity. For instance, matairesinol from axseeds,
which incorporates an aromatic ring system, exhibits strong estrogenic activity . Hence, the
stereochemistry of the lignan molecule can also impact its estrogenic activity . Lignans can
exist in various stereoisomeric forms, each possessing distinct three-dimensional structures
(López-Rojas et al., 2022).
FIGURE 15.4 (a) The backbone structure of lignans consists of two phenylpropane units linked together by
a β–β′ bond, forming a bicyclic system known as a dibenzylbutane skeleton (a). Some examples of lignans that
exhibit phytoestrogen properties: matairesinol (b), secoisolariciresinol (c), arctigenin (d), enterolactone (e), and
enterodiol (f). (ChemDraw 20.1.1).
⏎
López-Rojas et al. (2022) studied the estrogenic and antiestrogenic qualities of lignan
derivatives derived from natural dibenzylbutyrolactones. Compared to 17β-estradiol,

367
these compounds had lower potency in triggering ERE-driven reporter gene expression
but reduced the potency and efcacy of pure agonists when combined with 17β-estradiol.
Binding assays conrmed the attachment of the lignan derivatives to rhERα-LBD, with
IC50 values between 0.16 μM (compound 14) and 6 μM (compound 4). For compound
14, its binding mode interactions were further analyzed through docking and molecular
simulations. In silico predictions showed that the potent lignan derivatives had favorable
drug-like attributes. The study highlighted compound 14’s potential as a treatment
for hormone-dependent cancers and emphasized the need for further research on these
compounds in ER-dependent diseases.
15.4.3 COUMESTANS
The classification of coumestrol as a phytoestrogen was based on its isolation by Bickoff
et al. (1957) from alfalfa, ladino clover, and strawberry clover , all belonging to the Fabaceae
family (Trifolium r epens L., Medicago sativa L., and T rifolium fragiferum L., respectively)
(Melo et al., 2010). While legumes are primarily where coumestrol is found in diets, traces
of it can also be spotted in vegetables such as Brussels sprouts and spinach. Clover and
soybean sprouts are noted to have the richest content of coumestrol among all sources.
Coumestans have a structure similar to that of isoflavones but with a five-membered ring
instead of a six-membered ring (Tu et al., 2021). The backbone structure of coumestans
consists of a benzopyran ring system fused to a benzene ring. The benzopyran ring
system contains a six-membered oxygen-containing ring (known as a pyran ring) fused
to a benzene ring. In coumestans, the benzopyran ring system is further substituted with
various functional groups, such as hydroxyl (–OH), methyl (–CH3), or methoxy (–OCH3)
groups, which can affect their biological activity (Figure 15.5). For example, the presence
of hydroxyl groups on the coumestan backbone allows them to bind to ERs in the body and
exhibit estrogenic activity (Jameera Begam et al., 2017).
FIGURE 15.5 The backbone structure of coumestans consists of a benzopyran ring system, with a hydroxyl
group at position 7 and a second aromatic ring attached at position 3. (ChemDraw 20.1.1).
⏎
The SAR of coumestans is complex and involves multiple structural features that
contribute to their estrogenic activity. Here are some key aspects of the SAR of phytoestrogen coumestans. (1) Coumestans contain a coumarin moiety, which is essential for
their estrogenic activity. This moiety consists of a benzene ring fused to a pyrone ring.

368
The position of substituents on the benzene ring and the nature of the substituents can affect
the estrogenic activity of coumestans. (2) The presence of hydroxyl groups in the coumarin
moiety is important for estrogenic activity. The number and position of hydroxyl groups
can affect the potency of coumestans as estrogen agonists or antagonists. (3) The substitution pattern of the B-ring of coumestans is also important for their estrogenic activity. In
general, hydroxyl or methoxy groups at the 6-position of the B-ring enhance estrogenic
activity, while substitutions at the 3-position reduce estrogenic activity. (4) The presence
of a prenyl group on coumestans can enhance their estrogenic activity. Prenylation refers
to the addition of an isoprene unit to a molecule. Coumestans with a prenyl group at the
4′-position of the B-ring are more potent estrogen agonists than those without a prenyl
group (Bhavnani et al., 2008). (5) The stereochemistry of coumestans can also affect their
estrogenic activity. In general, the S-conguration at the 3′-position of the prenyl group is
more favorable for estrogenic activity than the R-conguration.
Puerariacandollei and P. candollei var. mirica are plants native to Thailand and are
commonly used in traditional medicine (Warinsiriruk et al., 2022). The tuberous roots of
these plants contain several phytoestrogens, including miroestrol, deoxymiroestrol, and
isomiroestrol (Figure 15.6), which have been shown to have the strongest estrogenic
activity among the compounds found in the plant (Juengsanguanpornsuk et al., 2021).
These compounds can bind to ERs in the body and have been shown to help alleviate
menopause symptoms such as mood swings, vaginal dryness, and hot ashes. In addition
to deoxymiroestrol and miroestrol, Pueraria candollei var. mirica also contains other
phytoestrogens, such as genistein, daidzein, and coumestrol, which have been shown to
have weaker estrogenic effects than miroestrol and deoxymiroestrol. Puerariacandollei var.
mirica is commonly used in supplements and creams for menopause symptoms, as well as
for breast enlargement. However, additional studies are required to comprehensively grasp
the impacts of this plant on the body and any possible adverse reactions.
FIGURE 15.6 Chemical structures of the prominent coumestans found in P. candollei and P. candollei var.
mirifica roots: miroestrol, deoxymiroestrol, and isomiroestrol. (ChemDraw 20.1.1).
⏎
Coumestrol exhibits potential therapeutic properties against the development and
advancement of human skin cancer cells. It triggers apoptosis via the mitochondria, halts
the cell cycle, inhibits cell migration and invasion, and inuences the m-TOR-/PI3K/AKT
signaling pathway. These mechanisms suggest that coumestrol has potential as an anticancer agent for skin cancer. However, preclinical in vivo studies are required to identify

369
its toxicity, pharmacokinetics, and bioavailability before it can be used as a lead drug in
curbing skin cancer (Kuang et al., 2021).
15.4.4 STILBENES
Stilbene phytoestrogens are compounds naturally present in several plants, such as grapes,
berries, peanuts, and soybeans. Their defining feature is a central structure made of two
benzene rings linked by a double bond. The estrogenic activity of stilbenes arises from their
structural similarity to 17β-estradiol. The presence of hydroxyl (–OH) groups at specific
positions in the stilbene structure is considered crucial for their estrogenic activity. These
hydroxyl groups enable hydrogen bonding and other interactions with ERs, facilitating
binding and activation of the receptors.
Stilbenes have garnered signicant attention due to their potential health benets.
Research has explored their possible signicance in hormone-associated issues, including
menopausal symptoms, bone loss conditions such as osteoporosis, and specic cancer
forms. Their estrogenic activity can support the body’s hormonal balance and may have
therapeutic implications. It is worth noting that the estrogenic effects of stilbenes can
vary depending on the specic compounds and their concentration. Some stilbenes may
act as estrogenic agonists, mimicking the effects of estrogen, while others may exhibit
antagonistic properties, blocking or inhibiting ERs.
For instance, resveratrol (Figure 15.7) is a polyphenolic compound found in sources
such as grapes, berries, and peanuts. While resveratrol exhibits potent anticancer properties,
it does have some drawbacks attributed to its unstable double bond, rapid metabolism,
and short half-life, which render it susceptible to photoisomerization. To address these
limitations, researchers have explored the potential advantages of using the stable and
nontoxic form, trans-(E)-resveratrol. However, the biological and pharmacological
activities of the photoisomerized form, cis-(Z)-resveratrol, remain poorly understood
(Jang et al., 2022).
FIGURE 15.7 Chemical structure of trans-resveratrol. (ChemDraw 20.1.1).
⏎

370
Recently , Kobylka et al. (2022) studied the SAR of 1 1 resveratrol analogs to understand
their impact on the estrogen signaling pathway . These analogs, which included combinations
of methoxy groups and hydroxylated versions, were tested on ERs and estrogen-dependent
cells. The research revealed that these analogs can be both agonists and antagonists of
ERs. Specically, 3,4,4′5′-tetrahydroxystilbene and a few others might act as selective
modulators of these receptors. The study highlighted the dose-dependent activity of these
analogs and their potential therapeutic value for conditions such as breast cancer and
osteoporosis, paving the way for potential new treatments based on these compounds.
15.4.5 DIARYLHEPTANOIDS
The chemistry of diarylheptanoids involves a central seven-carbon (heptane) core structure with two aromatic (aryl) rings attached to it. The core structure typically consists of
a chain of carbon atoms with various substituents, such as hydroxyl groups (–OH) and
methoxy groups (–OCH
), attached at different positions. The specific arrangement and
3
substitution pattern of these aryl rings and functional groups contribute to the diversity
and biological activity of diarylheptanoids. The biosynthesis of diarylheptanoids involves
multiple enzymatic steps within plants. The key precursor for diarylheptanoid synthesis is
usually a molecule called phenylpropanoid, which is derived from the shikimate pathway.
Enzymatic processes such as hydroxylation, methylation, and glycosylation can alter
phenylpropanoids, resulting in the creation of diarylheptanoids with varied structures and
characteristics.
Regarding the diarylheptanoid phytoestrogens present in C. comosa rhizomes, these
substances have attracted interest for their potential health advantages, especially concerning
their estrogenic properties (Thongon et al., 2017; Yingngam et al., 2021; Limpongsa et al.,
2023). Figure 15.8 represents the basic structure of diarylheptanoids, which comprises a
seven-carbon chain with two aromatic rings located at the ends (Yingngam et al., 2018).
Here, “Ar” represents an aryl group, which is a type of organic molecule that contains an
aromatic ring. The two aryl groups in a diarylheptanoid can be the same or different, and
they can be attached to the seven-carbon chain at various positions. The specic arrangement of atoms and bonds in the backbone of each diarylheptanoid molecule can vary
depending on the plant species and other factors. However, the overall structure of these
compounds tends to be relatively rigid, which allows them to interact with ERs in the body
and mimic the effects of natural estrogens (Tipbunjong et al., 2017).
Different modications to this basic structure can lead to changes in their biological
activity. For example, the presence of hydroxyl groups at specic positions on the aromatic
rings can increase their estrogenic activity. Several SAR studies have been conducted
on these compounds, and they have identied some important structural features that
are responsible for their estrogenic activity. For instance, having a phenolic hydroxyl
group at the 3′ and 4′ positions of the aromatic ring results in increased estrogenic
activity. Enhancing the activity of diarylheptanoid analogs can benet from introducing a
hydroxyl group on the aromatic ring, which can further be altered with isosteric groups.
Additionally, the reduced polarity of the second phenyl ring allows for a better t within

371
the hydrophobic cavity of the ERβ receptor (Jongkon and Tangyuenyongwatana, 2014).
Likewise, a methoxy group at the 3 position of the alternate aromatic ring can boost their
efcacy. Other modications, such as the length of the carbon chain or the substitution
pattern on the aromatic rings, can also affect their activity. For example, for the phenyl
ring to effectively conform to the receptor-binding pocket, diarylheptanoids rely on the
inherent exibility of the heptyl chain, while substitutions on the aromatic rings can lead
to changes in their binding afnity for ERs (Winuthayanon et al., 2009; Jongkon and
Tangyuenyongwatana, 2014; Tipbunjong et al., 2017).
FIGURE 15.8 Photograph of Curcuma comosa Roxb. and the chemical structures of three compounds:
(a) compound 1, which is 1-(3,4-dihydroxyphenyl)-7-phenyl-(6E)-6-heptan-3-ol, (b) compound 2, which is
(4E,6E)-1,7-diphenylhepta-4,6-dien-3-ol, and (c) compound 3, which is (6E)-1,7-dipheylhept-6-en-3-ol.
⏎
In summary, the SAR of phytoestrogens is complex and involves the presence and
position of hydroxyl groups on the molecule, as well as the structure of the compound itself.
Understanding the SAR of phytoestrogens can help in the design of new compounds with
improved estrogenic or antiestrogenic activity to address conditions such as osteoporosis,
breast malignancies, and cardiovascular diseases.
15.5 COMPARING POTENCY AND EFFICACY OF PHYTOESTROGENS ON VARIOUS PATHWAYS
According to the literature, the potency of phytoestrogens has been evaluated using various
test methods, including bioassays, in vitro receptor-binding studies, and clinical assays
(Juengsanguanpornsuk et al., 2021; Kornhuber et al., 2021). Nevertheless, estimating
estrogen potency is complex due to various test-related variables, such as animal choice,

372
target organ response, dosage, timing, and drug delivery method. Furthermore, extrapolating
data from animals to humans adds complexity. From these tests, 17β-estradiol is seen as
the most potent estrogen. Estrone is approximately 50–70% less active than 17β-estradiol,
while estriol is the least potent, at only one-tenth the potency of estradiol. T ransformations
of these estrogens usually yield inactive products (Das et al., 2022).
The rodent uterotrophic assay is widely utilized in vivo test to assess the estrogenic
potency and mechanisms of action of phytoestrogens. Various protocols have been developed involving the use of immature, hypophysectomized, or ovariectomized rats and mice
and the administration of the test substance either orally or subcutaneously. However, the
author believes that evaluating the stimulation of uterine growth caused by a compound or
a plant extract alone is insufcient to fully characterize its estrogenicity.
Loutchanwoot et al. (2016) studied the estrogenic potency of puerarin, found in Pueraria
lobata and P. candollei var. mirica, on pituitary function in female rats. The research focused
on its effects on plasma prolactin, growth hormone levels, and estrogen-regulated genes in the
pituitary, comparing puerarin to a known ER agonist over 12 weeks. Puerarin showed weak
estrogen-like activities, inuencing the ERβ and TERP-1/-2 pathways and leading to altered
mRNA expression and growth hormone levels. These ndings provide initial evidence of
puerarin’s subtle estrogenic effects on the pituitary in ovariectomized rats.
15.5.1 POTENCY AND EFFICACY OF PHYTOESTROGENS ON DIFFERENT PATHWAYS
Phytoestrogens have been studied for their potential health benefits, particularly for women’ s
health. Comparing the potency and efficacy of phytoestrogens on different pathways, it is
important to note that different phytoestrogens have varying levels of potency and activity
on different ERs and pathways in the body. Here are some key points to consider. (1)
Phytoestrogens can bind to both ERα and ERβ (Sim et al., 2022). The potency and efficacy
of phytoestrogens on these receptors can vary depending on the specific compound. (2)
Some phytoestrogens, such as genistein and daidzein found in soy products, have been
found to have a higher affinity for ERβ than ERα. The potential health advantages of this
could be significant, given that ERβ is believed to offer protection against specific cancers,
including breast and prostate cancer (Ahlin et al., 2023). (3) In addition to their effects
on ERs, phytoestrogens can also have other effects on the body, such as antioxidant and
anti-inflammatory effects (Yen et al., 2023). The potency and efficacy of these effects
may also vary depending on the specific compound. Thus, the potency and efficacy of
phytoestrogens on different pathways can vary depending on the specific molecule and the
receptor or pathway being targeted.
For example, Procházková et al. (2017) studied phytoestrogens and sterols in water
samples with abundant cyanobacteria. They developed methods to analyze eight avonoids
and ve sterols. Flavonoid concentrations varied, with some being undetectable, while
sterols reached up to 2.25 μg/l. Using an in vitro assay, coumestrol was identied as the
most potent phytoestrogen. However, only 8.5% of the estrogenic activity in the water
came from phytoestrogens, hinting that other compounds, possibly human-made steroid
estrogens, contributed more to the estrogenic effects in these waters.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
